We are live on ! Find out more
CI

CPMG Inc Portfolio holdings

AUM $37.1M
1-Year Est. Return 74.35%
This Fund
S&P 500
This Quarter Est. Return
+19.84%
1 Year Est. Return
+74.35%
3 Year Est. Return
+878.37%
5 Year Est. Return
+1,872.39%
10 Year Est. Return
AUM
$510M
AUM Growth
+$12.1M
Cap. Flow
-$74.6M
Cap. Flow %
-14.63%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
1
Closed
1

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRCT icon
1
Procept Biorobotics
PRCT
$1.09B
$375M 73.64%
9,055,341
-1,863,052
-17% -$74.3M
RETA
2
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$72.8M 14.28%
2,896,901
TIL icon
3
Instil Bio
TIL
$50.9M
$39.8M 7.8%
410,923
APEN
4
DELISTED
Apollo Endosurgery, Inc.
APEN
$21.8M 4.28%
3,963,641
+58,416
+1% +$324K
IWB icon
5
iShares Russell 1000 ETF
IWB
$48B
-2,871
Closed -$596K

Similar funds

CPMG Inc's Q3 2022 Portfolio in Review

As of Q3 2022, CPMG Inc held 5 positions worth $510M, up 2.4% from $498M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

CPMG Inc withdrew a net $74.6M in Q3 2022, closing 1 position and reducing 1 holding. Its most notable exit was iShares Russell 1000 ETF, an estimated $596K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

Against the trend, CPMG Inc added an estimated $324K to Apollo Endosurgery, Inc..

  • CPMG Inc added most to Apollo Endosurgery, Inc. in Q3 2022, an estimated $324K increase.
  • CPMG Inc's biggest Q3 2022 reduction was Procept Biorobotics, cutting an estimated $74.3M.
  • CPMG Inc fully exited iShares Russell 1000 ETF in Q3 2022, selling an estimated $596K.
  • CPMG Inc's ten largest holdings make up 100% of its $510M portfolio in Q3 2022.
  • CPMG Inc opened 0 new positions and closed 1 in Q3 2022.
  • CPMG Inc's portfolio value rose 2.4% quarter-over-quarter to $510M.

Based on CPMG Inc's 13F filing for Q3 2022, filed 14 Nov 2022.